Study ID: CTSU R0920
Title:

Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer

Description:

The purpose of this study is to compare the effects of radiation therapy alone versus radiation therapy and cetuximab on a participant┬┐s cancer to find out which has a better outcome. Participants in this study have head and neck cancer and have an intermediate risk of recurrence following surgery. Cetuximab the chemotherapy drug in this study, may delay or prevent tumor growth by blocking certain cellular chemical pathways that lead to the tumor development.

Location:
Bemidji Clinic, Bismarck Region, Fargo Region, Sioux Falls Region
Principal Investigator:
Preston Steen, MD,Preston Steen, MD,Preston Steen, MD
Disease:
Head & Neck
Stage:
Phase III

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list